July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee - 07/23/2026 | FDA https://www.fda.gov/advisory-commit...rmacy-compounding-advisory-committee-07232026
The bulk drug substances listed below are what the Committee will discuss on July 23, 2026, all of them under consideration for the 503A Bulks List: MOTs-C-related (MOTs-C (free base)/ MOTs-C acetate), TB-500-related (TB-500 (free base)/ TB-500 acetate), KPV-related (KPV (free base)/ KPV acetate), and BPC-157-related (BPC-157 (free base)/ BPC-157 acetate). The chart below identifies the use(s)
The bulk drug substances listed below are what the Committee will discuss on July 23, 2026, all of them under consideration for the 503A Bulks List: MOTs-C-related (MOTs-C (free base)/ MOTs-C acetate), TB-500-related (TB-500 (free base)/ TB-500 acetate), KPV-related (KPV (free base)/ KPV acetate), and BPC-157-related (BPC-157 (free base)/ BPC-157 acetate). The chart below identifies the use(s)